Breaking News Instant updates and real-time market news.

2022-12-14 08:20:28 MRSN Mersana Therapeutics $7.03 / +0.28 (+4.15%) 08:20 12/14/22 12/14 08:20 12/14/22 08:20	Mersana Therapeutics announces E.C. designated UpRi Orphan Medicinal product Mersana Therapeutics announced that the European Commission, E.C., has designated upifitamab rilsodotin, UpRi, as an orphan medicinal product for the treatment of ovarian cancer. UpRi is Mersana's first-in-class NaPi2b-targeting ADC with a novel scaffold-linker-payload that is designed to enable a high drug-to-antibody ratio and controlled bystander effect. "Receiving this orphan designation in the European Union is an important regulatory milestone for Mersana as we seek to expedite UpRi's global development," said Anna Protopapas, President and Chief Executive Officer of Mersana Therapeutics. "This designation reinforces the unmet needs that patients with ovarian cancer continue to face today. We look forward to advancing our ongoing clinical trials, which aim to establish UpRi as a foundational medicine in ovarian cancer."

2022-12-14 08:20:28

MRSN

Mersana Therapeutics

$7.03 / +0.28 (+4.15%)

08:20

12/14/22

12/14

08:20

12/14/22

08:20

Mersana Therapeutics announces E.C. designated UpRi Orphan Medicinal product

Mersana Therapeutics announced that the European Commission, E.C., has designated upifitamab rilsodotin, UpRi, as an orphan medicinal product for the treatment of ovarian cancer. UpRi is Mersana's first-in-class NaPi2b-targeting ADC with a novel scaffold-linker-payload that is designed to enable a high drug-to-antibody ratio and controlled bystander effect. "Receiving this orphan designation in the European Union is an important regulatory milestone for Mersana as we seek to expedite UpRi's global development," said Anna Protopapas, President and Chief Executive Officer of Mersana Therapeutics. "This designation reinforces the unmet needs that patients with ovarian cancer continue to face today. We look forward to advancing our ongoing clinical trials, which aim to establish UpRi as a foundational medicine in ovarian cancer."

OTHER BREAKING NEWS FROM THE FLY

General news	Treasury's $15 B 10-year TIPS reopening was rather tepid » 13:35 03/23/23 03/23 13:35 03/23/23 13:35 $ECON Economic Data / + Treasury's $15 B… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Technical Analysis $ECON Economic Data / + 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' $ECON Economic Data / + $ECON Economic Data / + 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/07/23 Powell tells Congress data from January partly reversed softening trends 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says $ECON Economic Data / + 03/22/23 What You Missed On Wall Street On Wednesday 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/08/23 What You Missed On Wall Street On Wednesday $ECON Economic Data / + 03/22/23 Fed says 'additional policy firming may be appropriate'
Options	Futu Holdings put volume heavy and directionally bearish » 13:35 03/23/23 03/23 13:35 03/23/23 13:35 FUTU Futu Holdings $48.81 / +2.735 (+5.94%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FUTU Futu Holdings $48.81 / +2.735 (+5.94%) 02/13/23 Futu Holdings announces connectivity, market data partnership with BOT in China 12/30/22 Futu Holdings down 27% at $43.07 after CSRC warning on mainland China operations 12/30/22 Futu Holdings to 'fully cooperate' with CSRC, 'take all necessary measures' 12/29/22 Futu to postpone listing of Class A shares on Hong Kong Stock Exchange FUTU Futu Holdings $48.81 / +2.735 (+5.94%) 01/03/23 CLSA Futu Holdings downgraded to Reduce from Buy at CLSA 12/30/22 BofA BofA double downgrades Futu to Underperform after 'other regulatory boot drops' 12/30/22 BofA Futu Holdings downgraded to Underperform from Buy at BofA 12/30/22 Daiwa Daiwa says 'stay calm,' Futu regulation removes overhang FUTU Futu Holdings $48.81 / +2.735 (+5.94%) 11/21/22 Futu Holdings reports Q3 EPS 68c, one est. 55c FUTU Futu Holdings $48.81 / +2.735 (+5.94%) 12/30/22 Futu, UP Fintech told by regulator to stop 'illegal' activities, Bloomberg says FUTU Futu Holdings $48.81 / +2.735 (+5.94%) 01/21/23 Short Report: Bear appetite for Virgin Galactic sustained despite stock bounce 01/07/23 Short Report: Bad News Bears continue to claw Silvergate, Futu Holdings 01/03/23 What You Missed On Wall Street This Morning 12/30/22 What You Missed On Wall Street On Friday 03/28/23 Futu Holdings - FUTU FUTU Futu Holdings $48.81 / +2.735 (+5.94%) 03/15/23 Futu Holdings put volume heavy and directionally bearish 03/01/23 Unusually active option classes on open March 1st 02/21/23 Unusually active option classes on open February 21st 02/15/23 Futu Holdings call volume above normal and directionally bullish
Hot Stocks	Block exploring legal action against Hindenburg after 'misleading' report » 13:34 03/23/23 03/23 13:34 03/23/23 13:34 SQ Block $62.01 / -10.62 (-14.62%) Block said in a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SQ Block $62.01 / -10.62 (-14.62%) 13:33 Today Block calls Hindenburg report 'factually inaccurate and misleading' 12:00 Today Block falls -13.2% 10:00 Today Block falls -19.4% 09:47 Today Block falls -19.9% SQ Block $62.01 / -10.62 (-14.62%) 12:02 Today RBC Capital RBC Capital issues initial thoughts on Block short report 11:54 Today KeyBanc KeyBanc sees 'no merit' to disparaging claims made against Block by short seller 11:02 Today Raymond James Block short report doesn't include 'bombshell,' says Raymond James 10:55 Today Mizuho Block short report makes some valid arguments, says Mizuho SQ Block $62.01 / -10.62 (-14.62%) 02/23/23 Block reports Q4 EPS 22c, consensus 30c 02/23/23 Notable companies reporting after market close 11/03/22 Block reports Q3 adjusted EPS 42c, consensus 23c 11/03/22 Notable companies reporting after market close SQ Block $62.01 / -10.62 (-14.62%) 08:35 Today Hindenburg short Block, accuses of facilitating 'fraud against consumers' 08:32 Today Hindenburg short Block, accuses of inflated metrics and 'frictionless fraud' 02/11/23 Toast more than just restaurant payments, stock looks like a buy, Barron's says 11/28/22 Crypto lender BlockFi files for bankruptcy amid FTX 'entanglement,' NYT says SQ Block $62.01 / -10.62 (-14.62%) 12:12 Today What You Missed On Wall Street This Morning 09:12 Today Fly Intel: Pre-market Movers 03/18/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/16/23 What You Missed On Wall Street On Thursday SQ Block $62.01 / -10.62 (-14.62%) 03/17/23 Square call volume above normal and directionally bullish 02/23/23 Square options imply 7.8% move in share price post-earnings 01/23/23 Unusually active option classes on open January 23rd 01/19/23 Square put volume heavy and directionally bearish
Hot Stocks	Block calls Hindenburg report 'factually inaccurate and misleading' 13:33 03/23/23 03/23 13:33 03/23/23 13:33 SQ Block $62.18 / -10.45 (-14.39%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SQ Block $62.18 / -10.45 (-14.39%) 12:00 Today Block falls -13.2% 10:00 Today Block falls -19.4% 09:47 Today Block falls -19.9% 08:55 Today Block extends decline to 20% after Hindenburg Research short report SQ Block $62.18 / -10.45 (-14.39%) 12:02 Today RBC Capital RBC Capital issues initial thoughts on Block short report 11:54 Today KeyBanc KeyBanc sees 'no merit' to disparaging claims made against Block by short seller 11:02 Today Raymond James Block short report doesn't include 'bombshell,' says Raymond James 10:55 Today Mizuho Block short report makes some valid arguments, says Mizuho SQ Block $62.18 / -10.45 (-14.39%) 02/23/23 Block reports Q4 EPS 22c, consensus 30c 02/23/23 Notable companies reporting after market close 11/03/22 Block reports Q3 adjusted EPS 42c, consensus 23c 11/03/22 Notable companies reporting after market close SQ Block $62.18 / -10.45 (-14.39%) 08:35 Today Hindenburg short Block, accuses of facilitating 'fraud against consumers' 08:32 Today Hindenburg short Block, accuses of inflated metrics and 'frictionless fraud' 02/11/23 Toast more than just restaurant payments, stock looks like a buy, Barron's says 11/28/22 Crypto lender BlockFi files for bankruptcy amid FTX 'entanglement,' NYT says SQ Block $62.18 / -10.45 (-14.39%) 12:12 Today What You Missed On Wall Street This Morning 09:12 Today Fly Intel: Pre-market Movers 03/18/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/16/23 What You Missed On Wall Street On Thursday SQ Block $62.18 / -10.45 (-14.39%) 03/17/23 Square call volume above normal and directionally bullish 02/23/23 Square options imply 7.8% move in share price post-earnings 01/23/23 Unusually active option classes on open January 23rd 01/19/23 Square put volume heavy and directionally bearish
Conference/Events	BioLife Solutions to host virtual analyst day » 13:25 03/23/23 03/23 13:25 03/23/23 13:25 BLFS BioLife Solutions $22.01 / +1.01 (+4.81%) Virtual Analyst Day to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events BLFS BioLife Solutions $22.01 / +1.01 (+4.81%) 03/10/23 BioLife Solutions reports 'immaterial financial exposure' to Silicon Valley Bank 01/26/23 iVexSol closes $23.8M Series A-3 financing 11/21/22 BioLife Solutions provides update on intellectual property estate 10/03/22 BioLife Solutions COO Roderick de Greef to retire BLFS BioLife Solutions $22.01 / +1.01 (+4.81%) 03/17/23 Stephens BioLife Solutions price target lowered to $27 from $31 at Stephens 01/05/23 Northland BioLife Solutions named a top pick 2023 at Northland 12/28/22 Stephens Stephens carries over seven stocks to 'Best Ideas' list for 2023 12/06/22 Northland BioLife Solutions weakness creates buying opportunity, says Northland BLFS BioLife Solutions $22.01 / +1.01 (+4.81%) 03/16/23 BioLife Solutions sees 2023 revenue $188M-$202M, consensus $135.65M 03/16/23 BioLife Solutions reports Q4 EPS ($1.15), consensus (17c) 01/09/23 BioLife Solutions sees FY23 revenue $188M-$202M, consensus $195.45M 01/09/23 BioLife Solutions sees FY22 revenue $161.9M, consensus $160.92M 13:30 Today BioLife Solutions
Periodicals	Home Point 'closer to being sold,' Inside Mortgage Finance says » 13:20 03/23/23 03/23 13:20 03/23/23 13:20 HMPT Home Point Capital $2.08 / +0.03 (+1.46%) Home Point Capital is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events HMPT Home Point Capital $2.08 / +0.03 (+1.46%) 11/11/22 Wedbush Home Point Capital upgraded to Outperform from Neutral at Wedbush 09/30/22 Piper Sandler Home Point Capital price target lowered to $3 from $3.50 at Piper Sandler 08/15/22 Wedbush Home Point Capital downgraded to Neutral from Outperform at Wedbush 04/13/22 JMP Securities Home Point downgraded to Market Perform from Outperform at JMP Securities HMPT Home Point Capital $2.08 / +0.03 (+1.46%) 03/09/23 Home Point Capital reports Q4 EPS (27c), consensus (20c) 11/10/22 Home Point Capital reports Q3 EPS (68c), consensus (21c) 06/08/23 Home Point Capital Inc.
Hot Stocks	Freight Technologies announces 10-for-1 reverse share split » 13:17 03/23/23 03/23 13:17 03/23/23 13:17 FRGT Freight Technologies / + Freight Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly FRGT Freight Technologies / + 03/16/23 Freight Technologies introduces Fr8Now brand 02/15/23 Freight Technologies launches Fr8TMS 3.0, new shipper platform 01/30/23 Freight Technologies announces alliance with Majoba Logistics 01/20/23 Freight Technologies streamlines carrier onboarding process for Fr8APP FRGT Freight Technologies / + 03/07/23 Freight Technologies reports Q4 revenue $4.4M 01/05/23 Freight Technologies sees FY23 revenue $36M-$42M 11/21/22 Freight Technologies reports Q3 revenue $7.7M vs $5.6M last year FRGT Freight Technologies / + 11/21/22 What You Missed On Wall Street On Monday 11/21/22 What You Missed On Wall Street This Morning
Technical Analysis	NASDAQ market internals summary » 13:17 03/23/23 03/23 13:17 03/23/23 13:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 03/22/23 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 13:16 03/23/23 03/23 13:16 03/23/23 13:16 $NYE NYSE Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary 03/22/23 NYSE market internals summary
General news	10-year TIPS auction » 13:09 03/23/23 03/23 13:09 03/23/23 13:09 $ECON Economic Data / + Total Amount: $15B, Rate:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Technical Analysis $ECON Economic Data / + 03/22/23 Senators Scott, Warren unveil bipartisan Fed oversight legislation 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' $ECON Economic Data / + $ECON Economic Data / + 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/08/23 Biden to propose 25% billionaire tax, Bloomberg says 03/07/23 Powell tells Congress data from January partly reversed softening trends 01/30/23 Fed likely to raise funds rate benchmark by quarter percentage point, WSJ says $ECON Economic Data / + 03/22/23 What You Missed On Wall Street On Wednesday 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 03/08/23 What You Missed On Wall Street On Wednesday $ECON Economic Data / + 03/22/23 Fed says 'additional policy firming may be appropriate'

Hot Stocks	FiscalNote selected as inaugural 'trusted partner' for OpenAI's ChatGPT plug-in » 13:04 03/23/23 03/23 13:04 03/23/23 13:04 NOTE FiscalNote $1.35 / -0.01 (-0.74%) FiscalNote announced it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NOTE FiscalNote $1.35 / -0.01 (-0.74%) 03/15/23 FiscalNote announces Fireside State selected by Georgia Legislature 03/01/23 FiscalNote sees FY22 revenue approximately $113.8M, consensus $113.56M 01/30/23 FiscalNote falls -27.1% 01/30/23 FiscalNote falls -20.9% NOTE FiscalNote $1.35 / -0.01 (-0.74%) 12/14/22 EF Hutton FiscalNote assumed with a Buy at EF Hutton 11/15/22 Northland FiscalNote price target lowered to $9 from $13 at Northland 11/15/22 BTIG FiscalNote price target lowered to $11 from $14 at BTIG 11/14/22 DA Davidson FiscalNote downgraded to Neutral at DA Davidson after Q3 miss NOTE FiscalNote $1.35 / -0.01 (-0.74%) 03/01/23 FiscalNote sees FY23 revenue $136M - $141M, consensus $135.78M 11/14/22 FiscalNote sees FY22 revenue $112M-$114M, consensus $125.25M 11/14/22 FiscalNote reports Q3 EPS ($1.63), consensus (13c) 03/28/23 FiscalNote - NOTE
Periodicals	Lapse in Boeing credentials for Air Force One probed by Pentagon, WSJ says » 13:02 03/23/23 03/23 13:02 03/23/23 13:02 BA Boeing $198.56 / +2.11 (+1.07%) The Pentagon is examining… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BA Boeing $198.56 / +2.11 (+1.07%) 05:09 Today Boeing, Japan Airlines finalize order for 21 737-8 jets 03/17/23 Boeing awarded $1.95B Army contract modification 03/14/23 Boeing reports 28 commercial airplane deliveries, 5 orders in February 03/14/23 Saudi Arabian Airlines selects up to 49 Boeing 787 Dreamliners BA Boeing $198.56 / +2.11 (+1.07%) 07:14 Today Susquehanna Boeing orders from Japan sign of strong demand, says Susquehanna 05:50 Today Wolfe Research Boeing under $200 brings attractive entry point, says Wolfe Research 03/22/23 Wells Fargo Boeing price target lowered to $230 from $240 at Wells Fargo 03/16/23 Northcoast Boeing initiated with a Neutral at Northcoast BA Boeing $198.56 / +2.11 (+1.07%) 01/25/23 Boeing reports Q4 core EPS ($1.75), consensus 26c 01/24/23 Notable companies reporting before tomorrow's open 01/24/23 Notable companies reporting before tomorrow's open 10/26/22 Boeing reports Q3 core EPS ($6.18), consensus 2c BA Boeing $198.56 / +2.11 (+1.07%) 03/22/23 Boeing to take charges on KC-46 tanker amid quality issue, Reuters reports 03/17/23 Netflix, Boeing involved in U.S. business mission to Vietnam, Reuters says 03/16/23 Boeing resumes deliveries of 787 Dreamliner, Reuters reports 03/14/23 Amazon targets 2024 launch of first Kuiper internet satellites, Reuters reports BA Boeing $198.56 / +2.11 (+1.07%) 03/22/23 What You Missed On Wall Street On Wednesday 03/22/23 What You Missed On Wall Street This Morning 03/22/23 Fly Intel: Pre-market Movers 03/16/23 What You Missed On Wall Street On Thursday 04/18/23 Boeing Co. BA Boeing $198.56 / +2.11 (+1.07%) 02/24/23 Unusually active option classes on open February 24th 01/25/23 Unusually active option classes on open January 25th 01/06/23 Unusually active option classes on open January 6th 12/12/22 Boeing call volume above normal and directionally bullish
Hot Stocks	Portfolio Recovery Associates announces settlement of CFPB matter » 12:52 03/23/23 03/23 12:52 03/23/23 12:52 PRAA PRA Group $39.52 / -0.21 (-0.53%) PRA Group announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings PRAA PRA Group $39.52 / -0.21 (-0.53%) 03/01/23 JMP Securities PRA Group price target raised to $50 from $42 at JMP Securities 01/13/23 JMP Securities PRA Group price target lowered to $42 from $47 at JMP Securities PRAA PRA Group $39.52 / -0.21 (-0.53%) 02/27/23 PRA Group reports Q4 EPS 41c, consensus 32c 11/03/22 PRA Group reports Q3 EPS 63c, consensus 46c
Conference/Events	Par Technology management to meet with Needham » 12:48 03/23/23 03/23 12:48 03/23/23 12:48 PAR Par Technology $32.13 / +0.55 (+1.74%) Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PAR Par Technology $32.13 / +0.55 (+1.74%) 01/17/23 Par Technology subsidiary announces $21M U.S. Navy Award PAR Par Technology $32.13 / +0.55 (+1.74%) 03/02/23 Craig-Hallum Par Technology price target raised to $42 from $35 at Craig-Hallum 01/18/23 Needham Par Technology price target raised to $43 from $30 at Needham 11/09/22 BTIG Par Technology price target lowered to $46 from $60 at BTIG 08/10/22 Craig-Hallum Par Technology price target raised to $50 from $40 at Craig-Hallum PAR Par Technology $32.13 / +0.55 (+1.74%) 03/01/23 Par Technology reports Q4 adjusted EPS (26c), consensus (45c) 11/09/22 Par Technology reports Q3 adjusted EPS (44c), consensus (41c) 03/28/23 Par Technology
Hot Stocks	ABB announces new $1B share buyback program » 12:45 03/23/23 03/23 12:45 03/23/23 12:45 ABB ABB $33.67 / +0.54 (+1.63%) ABB said its board… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Options ABB ABB $33.67 / +0.54 (+1.63%) 03/16/23 ABB to invest $20M to expand robotics factory in the U.S. 01/20/23 ABB to sell Power Conversion unit to AcBel Polytech for $505M in cash 12/05/22 Justice Department confirms $315M settlement with ABB 11/27/22 Fly Intel: Top five weekend stock stories ABB ABB $33.67 / +0.54 (+1.63%) 02/07/23 Kepler Cheuvreux ABB upgraded to Buy from Hold at Kepler Cheuvreux 02/06/23 Deutsche Bank ABB price target raised to CHF 28 from CHF 27 at Deutsche Bank 01/10/23 Societe Generale ABB price target raised to CHF 32 from CHF 30 at Societe Generale 11/30/22 Exane BNP Paribas ABB downgraded to Underperform from Neutral at Exane BNP Paribas ABB ABB $33.67 / +0.54 (+1.63%) 11/27/22 ABB near $325M settlement to resolve bribery allegations, WSJ reports ABB ABB $33.67 / +0.54 (+1.63%) 02/07/23 Largest borrow rate increases among liquid names
Options	GSK Pharma call volume above normal and directionally bullish » 12:45 03/23/23 03/23 12:45 03/23/23 12:45 GSK GSK $35.49 / +0.585 (+1.68%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSK GSK $35.49 / +0.585 (+1.68%) 03/14/23 GSK says MenABCWY combination vaccine candidate met all 11 primary endpoints 03/14/23 GSK reports China NMPA accepts regulatory submission for Nucala 03/01/23 GSK says FDA Advisory Committee supports effectiveness and safety of RSV vaccine 02/13/23 Vir Biotechnology announces amended collaboration pact with GSK GSK GSK $35.49 / +0.585 (+1.68%) 03/17/23 Deutsche Bank GSK upgraded to Buy from Hold at Deutsche Bank 02/26/23 Goldman Sachs GSK reinstated with a Buy at Goldman Sachs 02/10/23 Berenberg GSK price target raised to 1,730 GBp from 1,580 GBp at Berenberg 02/02/23 JPMorgan GSK price target raised to 1,400 GBp from 1,350 GBp at JPMorgan GSK GSK $35.49 / +0.585 (+1.68%) 02/01/23 GSK reports Q4 adjusted EPS 25.8p vs. 23.6p last year 11/02/22 GSK reports Q3 adjusted EPS 46.9p, up 25% AER, 11% CER GSK GSK $35.49 / +0.585 (+1.68%) 03/01/23 FDA advisers vote 12-0 that data show GSK RSV vaccine effective, Bloomberg says 03/01/23 FDA advisers vote 10-2 that data show GSK RSV vaccine safe, Bloomberg reports 12/30/22 GSK seeks under-appreciated biotechs 'hiding in plain sight', FT reports 12/24/22 Pfizer, Moderna among vaccine makers to watch in 2023, Barron's says GSK GSK $35.49 / +0.585 (+1.68%) 12/30/22 What You Missed On Wall Street On Friday 12/30/22 What You Missed On Wall Street This Morning 12/16/22 Biotech Alert: Searches spiking for these stocks today 12/15/22 Biotech Alert: Searches spiking for these stocks today 05/03/23 PDUFA Date for Arexvy GSK GSK $35.49 / +0.585 (+1.68%) 03/15/23 GSK Pharma call volume above normal and directionally bullish 03/01/23 GSK Pharma put volume heavy and directionally bearish 12/12/22 GSK Pharma call volume above normal and directionally bullish 11/07/22 GSK Pharma put volume heavy and directionally bearish
Conference/Events	Cara Therapeutics management to meet virtually with Needham » 12:44 03/23/23 03/23 12:44 03/23/23 12:44 CARA Cara Therapeutics $5.12 / -0.07 (-1.35%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CARA Cara Therapeutics $5.12 / -0.07 (-1.35%) 03/10/23 Cara Therapeutics says it does not hold cash deposits, securities at SVB 03/06/23 Cara sees cash, cash equivalents sufficient to fund ops into at least 1H24 02/08/23 Cara Therapeutics announces results from Phase 2 trial of oral Difelikefalin 11/29/22 KemPharm appoint Christopher Posner to board of directors CARA Cara Therapeutics $5.12 / -0.07 (-1.35%) 03/07/23 BofA Cara Therapeutics downgraded to Underperform from Neutral at BofA 03/07/23 Needham Cara Therapeutics price target lowered to $22 from $26 at Needham 03/07/23 Canaccord Cara Therapeutics price target lowered to $25 from $29 at Canaccord 03/07/23 H.C. Wainwright Cara Therapeutics price target lowered to $20 from $25 at H.C. Wainwright CARA Cara Therapeutics $5.12 / -0.07 (-1.35%) 03/06/23 Cara Therapeutics reports Q4 EPS (56c), consensus (32c) 11/07/22 Cara Therapeutics reports Q3 EPS (43c), consensus (42c) CARA Cara Therapeutics $5.12 / -0.07 (-1.35%) 03/08/23 What You Missed On Wall Street On Wednesday 03/08/23 What You Missed On Wall Street This Morning 03/07/23 What You Missed On Wall Street On Tuesday 03/07/23 What You Missed On Wall Street This Morning 03/29/23 Cara Therapeutics
Conference/Events	Zuora management to meet with Needham » 12:43 03/23/23 03/23 12:43 03/23/23 12:43 ZUO Zuora $9.53 / +0.205 (+2.20%) Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ZUO Zuora $9.53 / +0.205 (+2.20%) 03/10/23 Zuora opens new office in India 03/02/23 Zuora rises 13.2% 12/07/22 Zuora falls -14.1% 12/07/22 Zuora falls -9.7% ZUO Zuora $9.53 / +0.205 (+2.20%) 03/15/23 Jefferies Zuora price target raised to $10 at Jefferies after meetings with management 03/03/23 Canaccord Zuora price target raised to $16 from $15 at Canaccord 01/31/23 Lake Street Zuora initiated with a Buy at Lake Street 12/09/22 Canaccord Zuora price target lowered to $15 from $20 at Canaccord ZUO Zuora $9.53 / +0.205 (+2.20%) 03/01/23 Zuora sees FY24 adjusted EPS 7c-11c, consensus 8c 03/01/23 Zuora sees Q1 adjusted EPS 0c-1c, consensus 0c 03/01/23 Zuora reports Q4 adjusted EPS (4c), consensus (6c) 12/06/22 Zuora narrows FY23 FY23 EPS view to (16c)-(15c) from (18c)-(14c) ZUO Zuora $9.53 / +0.205 (+2.20%) 03/01/23 Fly Intel: After-Hours Movers 12/06/22 Fly Intel: After-Hours Movers 03/29/23 Zuora ZUO Zuora $9.53 / +0.205 (+2.20%) 12/06/22 Zuora options imply 10.5% move in share price post-earnings
Recommendations	Essential Properties price target lowered to $27 from $28 at Ladenburg » 12:38 03/23/23 03/23 12:38 03/23/23 12:38 EPRT Essential Properties Realty Trust $23.49 / +0.255 (+1.10%) Ladenburg analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events EPRT Essential Properties Realty Trust $23.49 / +0.255 (+1.10%) 12/01/22 Essential Properties Realty Trust raises dividend 1.9% to 27.5c per share EPRT Essential Properties Realty Trust $23.49 / +0.255 (+1.10%) 03/09/23 Mizuho Essential Properties Realty Trust price target raised to $27 from $26 at Mizuho 02/27/23 Truist Essential Properties Realty Trust price target raised to $29 from $27 at Truist 02/16/23 Stifel Essential Properties price target raised to $26.50 from $26.25 at Stifel 12/08/22 Mizuho Essential Properties Realty Trust price target raised to $25 from $21 at Mizuho EPRT Essential Properties Realty Trust $23.49 / +0.255 (+1.10%) 02/15/23 Essential Properties backs FY23 AFFO view $1.58-$1.64, consensus $1.63 02/15/23 Essential Properties reports Q4 AFFO 39c, consensus 39c 10/27/22 Essential Properties sees FY23 AFFO $1.58-$1.64, consensus $1.64 10/27/22 Essential Properties backs FY22 AFFO view $1.52-$1.54, consensus $1.55 17 Feb 02 Aug 05/12/23 2023 Real Estate Summit
Conference/Events	Stride management to meet with Barrington » 12:37 03/23/23 03/23 12:37 03/23/23 12:37 LRN Stride $38.01 / -0.05 (-0.13%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events LRN Stride $38.01 / -0.05 (-0.13%) 01/25/23 Stride rises 27.8% 01/25/23 Stride rises 29.0% 01/25/23 Stride rises 30.4% 01/24/23 Stride jumps 13% after Q2 earnings beat, FY23 guidance raise LRN Stride $38.01 / -0.05 (-0.13%) 03/10/23 Morgan Stanley Stride downgraded to Equal Weight from Overweight at Morgan Stanley 01/26/23 BMO Capital Stride price target raised to $48 from $47 at BMO Capital 10/26/22 Barrington Stride should be bought on post-earnings weakness, says Barrington 08/25/22 Morgan Stanley Stride upgraded to Overweight from Equal Weight at Morgan Stanley LRN Stride $38.01 / -0.05 (-0.13%) 01/24/23 Stride raises FY23 revenue view to $1.775B-$1.815B from $1.71B-$1.79B 01/24/23 Stride sees Q3 revenue $445M-$465M 01/24/23 Stride reports Q2 EPS $1.19, consensus $1.04 10/25/22 Stride guides initial FY23 revenue view of $.171B-$1.79B, consensus $1.78B LRN Stride $38.01 / -0.05 (-0.13%) 01/25/23 What You Missed On Wall Street On Wednesday 01/25/23 What You Missed On Wall Street This Morning 01/25/23 Fly Intel: Pre-market Movers 01/24/23 Fly Intel: After-Hours Movers 03/29/23 Stride 03/30/23 Stride

Options	Western Alliance put volume heavy and directionally bearish » 12:35 03/23/23 03/23 12:35 03/23/23 12:35 WAL Western Alliance $31.83 / -0.07 (-0.22%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options WAL Western Alliance $31.83 / -0.07 (-0.22%) 03/20/23 Western Alliance rises 9.5% 03/17/23 Western Alliance off lows after end of week update statement 03/17/23 Western Alliance CEO highlights 'cautious risk management' 03/17/23 Western Alliance says technology deposits less than 8% of total WAL Western Alliance $31.83 / -0.07 (-0.22%) 08:48 Today Truist Western Alliance price target lowered to $50 from $86 at Truist 05:37 Today Hovde Group Western Alliance initiated with an Outperform at Hovde Group 03/20/23 BofA Western Alliance deposit trends appear to be stabilizing, says BofA 03/15/23 UBS Western Alliance initiated with a Buy at UBS WAL Western Alliance $31.83 / -0.07 (-0.22%) 01/24/23 Western Alliance reports Q4 EPS $2.67, consensus $2.66 10/20/22 Western Alliance reports Q3 EPS $2.42, consensus $2.61 WAL Western Alliance $31.83 / -0.07 (-0.22%) 03/15/23 What You Missed On Wall Street On Wednesday 03/15/23 What You Missed On Wall Street This Morning 03/15/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/13/23 Fly Intel: Pre-market Movers WAL Western Alliance $31.83 / -0.07 (-0.22%) 03/20/23 Western Alliance put volume heavy and directionally bearish 03/20/23 Unusually active option classes on open March 20th 03/15/23 Largest borrow rate increases among liquid names
Recommendations	Quarterhill price target lowered to C$2 at Raymond James » 12:31 03/23/23 03/23 12:31 03/23/23 12:31 QTRHF Quarterhill $1.21 / + (+0.00%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings QTRHF Quarterhill $1.21 / + (+0.00%) 03/22/23 Quarterhill says strategic review for WiLAN remains ongoing 12/13/22 Quarterhill announces C$80M contract with ETC 10/21/22 Wi-LAN subsidiaries enter license, settlement agreement with Micron QTRHF Quarterhill $1.21 / + (+0.00%) 08/12/22 Raymond James Quarterhill price target lowered to C$2.75 from C$3.25 at Raymond James 04/21/22 Canaccord Quarterhill downgraded to Hold from Speculative Buy at Canaccord QTRHF Quarterhill $1.21 / + (+0.00%) 03/22/23 Quarterhill reports Q4 EPS (C$0.18) vs. (C$0.08) last year
Hot Stocks	Robert Half names Susan Haseley chief ESG and DEI officer » 12:30 03/23/23 03/23 12:30 03/23/23 12:30 RHI Robert Half $74.90 / +0.35 (+0.47%) Robert Half has promoted… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options RHI Robert Half $74.90 / +0.35 (+0.47%) 03/21/23 Robert Half appoints JoLynn Conway-James to CAO 02/09/23 Robert Half raises quarterly dividend to 48c from 43c per share 02/09/23 Robert Half announces additional 10M share repurchase program 10/21/22 Robert Half falls -10.9% RHI Robert Half $74.90 / +0.35 (+0.47%) 01/05/23 Exane BNP Paribas Robert Half initiated with an Underperform at Exane BNP Paribas 10/25/22 Jefferies Robert Half assumed with an Underperform at Jefferies 10/24/22 Barclays Robert Half price target lowered to $70 from $80 at Barclays 10/21/22 Baird Robert Half price target lowered to $88 from $95 at Baird RHI Robert Half $74.90 / +0.35 (+0.47%) 01/26/23 Robert Half sees Q1 EPS $1.10-$1.20, consensus $1.24 01/26/23 Robert Half reports Q4 EPS $1.37, consensus $1.36 10/20/22 Robert Half sees Q4 EPS $1.31-$1.41, consensus $1.54 10/20/22 Robert Half reports Q3 EPS $1.53, consensus $1.63 RHI Robert Half $74.90 / +0.35 (+0.47%) 01/26/23 Fly Intel: After-Hours Movers 10/21/22 Fly Intel: Pre-market Movers 10/20/22 Fly Intel: After-Hours Movers RHI Robert Half $74.90 / +0.35 (+0.47%) 02/10/23 Early notable gainers among liquid option names on February 10th
Recommendations	ECN Capital price target lowered to C$4 at Raymond James » 12:30 03/23/23 03/23 12:30 03/23/23 12:30 ECNCF ECN Capital $2.45 / +0.0284 (+1.17%) Raymond James lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ECNCF ECN Capital $2.45 / +0.0284 (+1.17%) 12:09 Today RBC Capital ECN Capital price target lowered to C$3.50 from C$4 at RBC Capital 11:46 Today National Bank ECN Capital price target lowered to C$4.50 from C$5 at National Bank 11:43 Today CIBC ECN Capital downgraded to Neutral from Outperformer at CIBC 11:42 Today TD Securities ECN Capital price target lowered to C$5.50 from C$7 at TD Securities
Syndicate	CBL International opens at $4.21, IPO priced at $4 » 12:27 03/23/23 03/23 12:27 03/23/23 12:27 BANL CBL International / + CBL International is a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Syndicate On The Fly 23 Mar BANL CBL International / + 11/12/22 Opening Day: Snail slides in public debut, then announces share buyback 10/29/22 Opening Day: Intel's Mobileye jumps in market return

Events

Earnings calls, analyst events, roadshows and more

DKS
Today at 14:00

Dick's Sporting Firm Sponsored Meetings

Virtual Meeting
ROKU
Today at 15:30

Roku Firm Sponsored Meetings

Virtual Meeting
NYXH
Today at 16:00

Nyxoah Firm Sponsored Meetings

Virtual Meeting
Today at 16:30

Fed Balance Sheet Level: Week 3/22/2023 Government Event
Today at 16:30

Fed Balance Sheet Total Assets W/W: 3/22/2023 Government Event
Today at 16:30

Fed Balance Sheet Reserve Bank Credit W/W: Week 3/22/2023 Government Event
KULR
Today at 16:30

KULR Technology - KULR Conference Calls
TMC
Today at 16:30

Metals Company - TMC Conference Calls
OXM
Today at 16:30

Oxford Industries - OXM Conference Calls
BCAB
Today at 16:30

BioAtla - BCAB Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	MGRX X MGRX Mangoceuticals IPO Managers: Boustead Priced at: $4.00 1.25M Shares
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs, JPMorgan, Morgan Stanley Priced at: $161.33 2.48M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	BANL X BANL CBL International IPO Managers: Pacific Century Priced at: $4.00 3.325M Shares
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	ETNB X ETNB 89bio Secondary Managers: BofA, SVB Securities & Evercore ISI $13.68 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Mersana Therapeutics announces E.C. designated UpRi Orphan Medicinal product

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access